Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 USD | -2.96% | -1.52% | -34.01% |
Mar. 12 | Ikena Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 12 | North American Morning Briefing : Inflation Data -2- | DJ |
Business Summary
Number of employees: 43
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Cancer Therapies
100.0
%
| 16 | 100.0 % | 9 | 100.0 % | -41.35% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 16 | 100.0 % | 9 | 100.0 % | -41.35% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Manfredi
FOU | Founder | 53 | 16-01-31 |
Jotin Marango
DFI | Director of Finance/CFO | 45 | 22-04-24 |
Caroline Germa
CTO | Chief Tech/Sci/R&D Officer | 52 | Feb. 28 |
Michelle Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
Rebecca Cohen
IRC | Investor Relations Contact | - | - |
Human Resources Officer | - | 21-05-31 | |
Jeffrey Ecsedy
PRN | Corporate Officer/Principal | 54 | 17-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 16-02-29 | |
David Bonita
BRD | Director/Board Member | 48 | - |
Director/Board Member | 55 | 20-11-30 | |
Iain Dukes
BRD | Director/Board Member | 65 | 16-10-31 |
Owen Hughes
CHM | Chairman | 49 | 22-12-14 |
Richard Wooster
BRD | Director/Board Member | 59 | 22-01-20 |
Mark Manfredi
FOU | Founder | 53 | 16-01-31 |
Maria Koehler
BRD | Director/Board Member | 67 | 21-04-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,889,525 | 38,958,058 ( 93.00 %) | 0 | 93.00 % |
Stock B | 0 | 4,153,439 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.01% | 65.15M | |
+18.49% | 47.02B | |
+48.77% | 41.86B | |
+0.52% | 41.76B | |
-4.27% | 28.8B | |
+11.85% | 26.05B | |
-22.05% | 19.15B | |
+4.63% | 12.55B | |
+29.83% | 12.34B | |
-3.94% | 11.82B |
- Stock Market
- Equities
- IKNA Stock
- Company Ikena Oncology, Inc.